Langer's early success was driven by his expansive interdisciplinary network of colleagues which influenced the problems he chose to investigate. He sought opportunities to change the world. His career began in a school without core disciplines, allowing more interdisciplinary work.
Currently, Langer's responsiveness and ability to multitask well have contributed to his success. He has built a powerful industry network through relationships formed in graduate school and beyond.
Langer's lab is organized collaboratively, with senior students guiding daily work while bringing major issues to Langer and collaborators. Equipment is shared in large, open rooms conducive to cross-pollinating ideas across disciplines through weekly seminars.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
135 views2 pages
The Langer Lab
Langer's early success was driven by his expansive interdisciplinary network of colleagues which influenced the problems he chose to investigate. He sought opportunities to change the world. His career began in a school without core disciplines, allowing more interdisciplinary work.
Currently, Langer's responsiveness and ability to multitask well have contributed to his success. He has built a powerful industry network through relationships formed in graduate school and beyond.
Langer's lab is organized collaboratively, with senior students guiding daily work while bringing major issues to Langer and collaborators. Equipment is shared in large, open rooms conducive to cross-pollinating ideas across disciplines through weekly seminars.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2
1)
What is behind Langer’s early success (before early 1990’s)? You may focus on several categories including knowledge, personal characteristics, chance, etc.
- Langer’s professional network reflected the interdisciplinary diversity of his
academic research and business collaborators. This expansive universe of colleagues affected not only how he researched, but also, more significantly, what problems he chose to investigate. -seeking an opportunity that were more pressing for humanity. Langer chooses only the problems that can change the world. -began his career in the School of Science’s Applied Biological Sciences (ABS), which had no core academic discipline or research agenda, more interdisciplinary and unencumbered by traditional scientific views.
2) What additional attributes drive Langer’s current success?
-Langer’s responsiveness derived from his ability to be unusually attentive while doing multiple tasks. -He is very good at creating relationships with colleagues. He has built an excellent network that goes back to his graduate school and postdoc days. He has also created incredibly powerful industry relationships and now serves on many scientific advisory boards and corporate boards of directors.
3) How is Langer’s lab organized and managed?
-Researchers who joined his lab had to have a passion for working on high- impact, high-risk problems that required a collaborative environment. -A subset of senior graduate students and postdoctoral associates guided the daily work, turning to Langer and his faculty collaborators for guidance and feedback on major issues. -The laboratory’s open architecture complemented its multidisciplinary environment. Equipment was shared, and the rooms were large and open. Students presented their work at weekly lab seminars that served to cross-pollinate ideas and spur investigations into new directions since the researchers derived from a variety of disciplines and backgrounds.
4) What are the challenges associated with the commercialization of scientific
knowledge and how Langer addressed them? Langer found that big ideas required an enormously substantial investment by the commercializing enterprise which was hard to come by. To address the issue, Langer found that small companies or startups were more willing to bring science to the market. For other people, a focus on commercialization might distract from the true mission of MIT. Langer’s generosity as a counterbalance to the forces that might lead some professors to conflicts of interest. He shares the glory and the value of what he has created with all the people he works with. A key part of the Langer Lab’s commercialization success was how it worked with MIT’s Technology Licensing Office. Researchers were encouraged to disclose their intellectual property before publishing it in academic journals to that faculty can get good patents written and filed before they publish--and not have to rush. This process allowed intellectual property protection to be developed in parallel to the research itself
5) What is the difference between new technology and business opportunity?
When does new technology change into a business opportunity? The difference between new technology and a business opportunity is that new technology doesn't always translate into a new business, but rather can just be a way for existing companies to enhance their current operations. A new technology doesn't always provide enough of a base for a new business. While an entrepreneurial opportunity doesn't always use new technology to kick start its growth but rather just simply a good idea. Langer describe the four elements of an ideal research project and the resulting symbiotic relationship between science and a science-based business. The ideal project, according to Langer, consists of four elements: 1. A huge idea conceived by recognizing a critical societal need that could be met by inventing a platform product. 2. A seminal paper based on research to establish the science underlying the product concept and its efficacy. 3. A blocking patent derived from patent disclosures written in parallel with the research process, the goal being to have patents filed before the research paper’s publication. 4. Preliminary in vivo studies in animals that demonstrated the efficacy of the research.